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Abstract: This longitudinal study of temporomandibular 
disorder (TMD) reports the association of psychosocial 
dysfunctions (depression, somatization without pain, 
somatization, and anxiety) with characteristic pain 
intensity (CPI), pain interference (PI), and number of 
disability days (DD) for subjects with TMD. Subjects 
(N=330) underwent a thorough series of assessments at 
baseline and follow-up (5-10 years later) to receive both 
Axis I and Axis II diagnoses per the Research Diagnostic 
Criteria for TMD (RDC/TMD). They reported their 
levels of CPI, PI, and DD at baseline and follow-up. 
Linear and log-binomial regression analyses were used to 
evaluate the change in CPI and PI and assess the risk of 
DD by baseline categories of psychosocial symptoms as 
measured by the Symptom Checklist (SCL-90). Linear 
regression analysis revealed that subjects with depression 
at baseline had higher PI at follow-up. Also, subjects 
with moderate to severe somatization with and without 
pain had higher CPI at follow-up than subjects without 
somatization. In conclusion, we found that psychosocial 
impairments (depression, somatization) were associated 
with increased characteristic of pain intensity, pain 
interference, and disability days at follow-up. 
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Introduction 
Temporomandibular disorder (TMD) is a term used 
to describe pain and dysfunction of the 
temporomandibular joint (TMJ) and muscles of 
mastication that control jaw motions (1). TMD 
consists of three subtypes and may affect one or 
more of these areas: myofascial (discomfort or pain 
in the muscles), internal derangement of the joint 
(displaced disc), and arthritis 
(degenerative/inflammatory joint disorders that 
affect TMJ) (2). 
Pain is the primary characteristic of TMD and pain 
relief is the main reason for seeking treatment (3, 
4). Other symptoms include disturbances in 
mandibular movement patterns, joints sound, 
and/or impairment in functional movement (2). 
TMD is considered to be one of the most common 
musculoskeletal conditions that cause pain and 
disability. Also, TMD pain is one of the three most 
prevalent types of chronic pain conditions globally 
after tension type headache and back pain (5, 6). 
TMD generally affects females more often than 
males, with ratios ranging from approximately 2:1 
to 8:1 (7, 8). Most patients presenting with 
symptoms are between 20 and 50 years of age, but 
frequency decreases after the age of 55 with an 
incidence rate of 4% across different populations 
(9, 10). The overall prevalence of TMD is reported 
to range from 4.6 to 15% (10, 11). Furthermore, a 
number of surveys have indicated that 20 to 25% of 
the United States (U.S.) population has experienced 
TMD-like pain; some estimates place the number 
of individuals suffering from TMD symptoms 
around 30 million, with 1 million cases diagnosed 
annually (10, 11, 12, 13). 
 
Literature review  
Etiology 
The etiology of TMD is considered to be 
multidimensional, but the importance of individual 
factors is still unclear. These factors include, but 
are not limited to: biomechanical (occlusal 
overloading and parafunctions such as bruxism); 
biological (increased levels of estrogen hormones); 
medical conditions (back pain, fibromyalgia, sleep 
apnea, and rheumatoid arthritis); macro trauma 
(head trauma, old or recent motor vehicle 
accidents, sports injuries); and bio-psychosocial 
factors (stress, anxiety or depression) (14, 15, 16, 
17, 18, 19, 20). 
Treatment Options 
The treatment of TMD is based on symptom 
management through conservative approaches, 
which show positive outcomes in the majority of 
patients. 
Self-care:Self-care: includes muscle exercises, 
physical therapy, massage, and stretching; applying 
warm and cold pack on the affected muscles; eating 
soft foods and avoiding eating crunchy and 
“gummy” foods; and taking over-the-counter 
analgesics under a doctor’s supervision (21, 22, 23, 
24,25). These are considered first-line treatments, 
and show high response rates, especially with 
patients who have no or low psychosocial aspects 
to their pain. 
Oral Appliances (Splints):Different types of oral 
appliances exist, ranging from thin to thick, soft to 
hard, over-the-counter to lab-made, and those that 
reposition the mandible in one direction or another. 
The main purpose of such appliances is to reduce 
parafunctional jaw activities (clenching, bruxism), 
to protect teeth and reduce the working load on the 
condyles. The overall results of treatment with oral 
appliances are promising for the reduction of pain 
when used as adjunctive treatment along with self-
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care (26, 27, 28). More comprehensive evidence-
based reviews of splint therapy, however, have 
shown equivocal results (29, 30). 
Arthrocentesis & Arthroscopy: Arthrocentesis and 
arthroscopy are considered the least invasive TMD 
surgical procedures. Arthrocentesis is usually 
suggested for sudden-onset, restricted jaw opening 
in patients with no significant history of TMJ 
problems. Arthroscopy is performed for a variety 
of purposes including returning the disc to a normal 
relationship with the condyle. It is not widely used 
and is usually used in cases of recurrent and 
prolonged displacement of the disc. While 
arthroscopic surgery and arthrocentesis may be 
performed to lubricate joint surfaces and reduce 
inflammation, more research is needed to identify 
long-term outcomes, particularly in the absence of 
disc repositioning or replacement (31, 32, 33). 
Joint replacement and condyloectomy: Joint 
replacement and condyloectomy are surgical 
procedures used to address severe structural 
damage to the joint (condyle and fossa) (34). 
Treatment outcome modifiers: Most patients, 
regardless of the subtype of TMD describe a 
favourable natural course of the disease, with self-
limiting and fluctuating symptoms that often seem 
to respond well to nonspecific treatments (35, 36, 
37). Some patients with TMD however, develop 
chronic pain representing a challenge for pain 
clinicians, especially because of the concurrent 
presence of psychosocial disorders and their 
relationship with pain (38). 
 
Psychosocial factors have been implicated in the 
initiation as well as in the permanence of TMD 
(39). Depression, somatic distress, and anxiety may 
be potential etiological risk factors for TMD-
related pain (40). The role of psychosocial factors 
in different stages of TMD has been intensively 
investigated, with equivocal results. Multiple 
studies indicate that psychosocial factors such as 
depression, stress, and anxiety play a role in the 
initiation and continuation of TMD as well as in 
patients’ response to treatment (41, 42). The role of 
those factors diverges in different cases according 
to the TMD diagnostic subgroup (43, 44). For 
instance, when the duration of pain increases, 
psychosocial factors may become more prominent. 
Even after reducing the pain, pain behavior and 
affect associated with it may continue and in some 
case may worsen (45). 
Although depression is more prevalent in patients 
with chronic pain, data concerning its co-
morbidity, especially in the chronic stage of pain, is 
diverse (46, 47, 48). Moreover, the role of anxiety 
in chronic pain is controversial. For instance, 
anxiety levels in patients with migraine and facial 
pain is positively related to muscle tenderness. 
However, multiple studies have failed to find a link 
between TMD and anxiety (49, 50, 51, 52, 53). 
The main research question is whether the course 
of TMD pain and related interference with daily 
activities in participants with psychosocial 
symptoms differs over a period of 5-10 years 
compared to participants without psychosocial 
symptoms in terms of 1) characteristic pain 
intensity (CPI), 2) pain interference (PI), and 3) 
disability days (DD). The research hypothesis of 
this research is that participants with psychosocial 
symptoms at baseline would have less 
improvement with regard to their TMD-related 
pain at follow-up compared with subjects who do 
not have psychosocial symptoms at baseline. 
Methodology  
This longitudinal research included subjects from 
the Research Diagnosis Criteria for 
Temporomandibular Disorder (RDC/TMD) 
Validation (baseline) and Impact (follow-up) 
projects. These multisite projects involve 
University of Health Sciences, King Edward 
Medical College, Allama Iqbal Medical College at 
Lahore, Pakistan. The RDC/TMD provides a dual-
axis biopsychosocial diagnostic approach assessing 
both physical (Axis I) and psychosocial (Axis II) 
diagnoses. While the Axis I diagnoses involve 
different muscle and joint disorders, diagnosing 
Axis II conditions involves instruments for the 
evaluation of different psychosocial aspects of 
pain. The research is described in detail elsewhere 
(2). Of those 705 subjects (case and control) who 
were included in RDC/TMD at baseline, 330 (case) 
were included in the study because they met 
primary criteria of having TMD at baseline and 
completing their Chronic Graded Pain Scale 
(CGPS) scores in both times. 
Measurement: Symptom Check List 90 (SCL-90) 
The SCL-90 is a questionnaire commonly used for 
self-report of psychosocial distress. The SCL-90 is 
validated for individuals aged 13 years and above. 
It contains 90 items and takes 12 - 15 minutes 
complete (55). Each item consists of a question to 
rate a specific compliant (e.g., “In the last month, 
how much have you been distressed by: Feeling 
easily annoyed or irritated”), and the response1 is 
scored on a five-point scale (0 = not at all, 1 = 
slight, 2 = somewhat, 3 = high, 4 = extremely), 
producing nine categories of primary symptom 
dimensions. Each primary symptom was 
categorized into normal, moderate, and severe. In 
this research, the three primary symptom 
dimensions evaluated were depression, 
somatization with and without pain, and anxiety. A 
number of studies have been conducted 
demonstrating the reliability, validity, and use of 
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this instrument (56, 57). Also, a subtype of 
somatization (without pain) was assessed in order 
to differentiate between subjects who have general 
somatic complaints in their body that do not 
involve pain. 
 
 
Results 
The total number of subjects who met the inclusion 
and exclusion criteria was 330. Subjects were 
mainly female (85.8%) with a mean (SD) age of 
37.95 (12.8) years (Table1). Follow-up time ranged 
from 5.75 to 10.7 years (mean (SD) = 7.88 (0.78) 
years). 
Duration of facial pain for 267 subjects reporting 
pain at baseline ranged from 0 to 40 years (mean 
(SD) = 9.8 (9.38) years). Among the 330 subjects 
at baseline, 32.1% (n=105) had moderate to severe 
depression; 26.1% (n=86) had moderate to severe 
somatization without pain; 70.9% (n=234) had 
moderate to severe somatization with pain; and 
20% (n=66) had moderate to severe anxiety (Table 
2). 
 
Table 1. Sociodemographic characteristics of subjects 
 Number Percentage 
Sex   
Male 47 14.2 
Female 283 85.8 
   
Education   
10-12 years 4 1.2 
13-15 years 135 40.8 
16-17 years 105 31.8 
18-19 years 56 17 
20 years 29 8.8 
Marital status   
Single 85 25.8 
Married 144 43.6 
Separated/divorced 45 13.6 
Widowed 4 1.2 
Household income   
<10k 50 15.2 
10-39k 101 30.6 
40-79k 114 34.5 
>=80k 62 18.8 
General Health 
Excellent 
Very good 
Good 
Poor 
General Health 
Excellent 
Very good 
Good 
Poor 
General Health 
Excellent 
Very good 
Good 
Poor 
Oral Health 
Excellent 
Very good 
Good 
Fair 
Poor 
39 
126 
110 
12 
43 
11.8 
38.2 
33.3 
3.6 
13 
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Table 2. Psychosocial symptoms at baseline 
Psychosocial dysfunction Moderate N (%) Severe N (%) Total N (%) 
    
depression 73 (22.4) 32 (9.7) 105 (32.1) 
    
somatization without pain 50 (15.2) 36 (10.9) 86 (26.1) 
    
somatization with pain 92 (27.9) 142 (43) 234 (70.9) 
    
anxiety 48 (14.5) 18 (5.5) 66 (20) 
    
 
Depression 
Depression was not associated with CPI at follow-
up after adjusting for baseline pain intensity, or 
adjusting for gender, age, and follow-up duration 
(Table 3).The linear regression for depression, 
identified a significant interaction between 
depression and baseline PI (interaction estimate 
[SE] = 0.24 [0.08]; p = .0014) (Table 3). On 
average subjects had lower levels of PI at follow-
up than baseline, but the reduction was smaller for 
subjects with moderate to severe depression than 
subjects without depression among subjects with 
elevated levels of PI at follow-up. For example, 
among subjects with a baseline PI one standard 
deviation above the mean (PI = 37.2), subjects with 
moderate to severe depression had a significantly 
smaller reduction in PI at follow-up than subjects 
without depression (estimate [SE] = 7.65 [2.28]; p 
= .0009). Whereas among subjects with a baseline 
PI one standard deviation below the mean (PI = 0), 
there was no difference by depression in the 
reduction of PI (estimate [SE] = -1.35 [2.20]; p = 
.54 (Figure 1). 
Figure 1. Interaction effect of baseline PI and 
depression on the change in PI 
 
 
 
Subjects with moderate to severe depression were 
more likely to have 1 or more disability days at 
follow-up than subjects without depression (RR = 
2.18; CI 95% 1.39 to 3.41; p= .0006). However, the 
increased risk was no longer statistically significant 
after controlling for baseline disability days, 
gender, age, and follow-up time (adjusted RR = 
1.50; 95% CI 0.96 to 2.33; p = .071) (Table 4). 
Somatization without Pain 
For somatization without pain, subjects with 
moderate to severe somatization had higher CPI at 
follow-up than subjects without somatization 
without pain (normal), after adjusting for baseline 
somatization, gender, age, and follow-up time 
[estimate (SE) = 5.27 (2.28); p = .022] (Table 3). 
For subjects with baseline CPI one standard 
deviation below the sample mean there was no 
significant interactions p= 0.85. Somatization was 
not associated with pain interference at follow-up 
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after adjusting for baseline pain interference, or 
adjusting for gender, age, and follow-up duration. 
There was a significant interaction between 
somatization without pain and having any disability 
days at baseline (p = .029). Among subjects 
without any disability days at baseline, subjects 
with moderate to severe somatization without pain 
were more likely to have 1 or more disability days 
at follow-up (RR(95%CI) = 2.94 (1.45, 5.92) p-
value = 0026). In contrast, for subjects with 1 or 
more disability days at baseline, the risk of 1 or 
more disability days at follow-up was similar for 
subjects with and without somatization without 
pain (RR (95% CI) = 1.14 (0.67, 1.90); p = .63) 
(Tables 4) 
 
 
Somatization with Pain 
For somatization with pain, subjects with moderate 
to severe somatization had higher pain intensity at 
follow-up than subjects without somatization 
(normal), after adjusting for baseline somatization, 
gender, age, and follow-up time [estimate (SE) = 
4.55 (2.4), p = .059]. Somatization was not 
associated with pain interference or disability days 
at follow-up (Tables 3 and 4). 
Anxiety 
Anxiety at baseline was not predictive of CPI 
[estimate (SE) = -0.32 (2.5), p = .90], PI [estimate 
(SE) = -0.94 (2.07), p = .65], and DD (RR (95%CI) 
= 1.34 (0.82, 2.16), p = .23) at follow-up (Tables 3 
and 4). 
Table 3. Linear regression results for CPI and PI scores (Model 4) 
Variables depression somatization somatization with anxiety 
   without pain pain   
 Estimate P- Estimate P- Estimate P- Estimate P- 
 (SE) value (SE) value (SE) value (SE) value 
Characteristic         
Pain Intensity         
Psychosocial 1.38 .53 5.27 0.021 4.55 .059 -0.32 .90 
variables (2.33)  (2.28)  (2.62)  (2.5)  
Baseline CPI -0.60 <.0001 -0.61 <.0001 -0.63 <.0001 -0.60 <.0001 
 (0.04)  (0.04)  (0.04)  (0.4)  
PI Score         
         
Psychosocial 2.96 .096* 2.34 .22 1.95 .30 -0.94 .65 
 (1.78)  (1.88)  (1.87)  (2.07)  
Baseline PI -0.68 <.0001 -0.67 <.0001 -0.68 <.0001 -0.66 <.0001 
 (0.04)  (0.04)  (0.04)  (0.04)  
*There was significant interaction between baseline depression and baseline PI, p = .0014. 
 
Table 4. Log-binomial results for any disability days (Model 4) 
Variable depression 
somatization w/o 
pain 
somatization with 
pain anxiety 
Any RR  95% P- RR 95% P- RR 95% P- RR 95% P- 
disability   CI value  CI value  CI value  CI value 
days              
Psychosocial 1.5  (0.96, .071 1.70 (1.06, .027 2.05 (0.87, .097 1.34 (0.82, .23 
   2.33)   2.71)   4.82)   2.16)  
Any DD at 3.1  (1.97, <.00 3.04 (1.87, <.00 2.94 (1.84, <.00 3.21 (1.98, <.0001 
baseline   5.0) 01  4.93) 01  4.67) 01  5.21)  
*There was significant interaction between baseline somatization without pain and any disability days at 
baseline, p = .029. 
  
ISSN: 2321-8819 (Online) 2348-7186 (Print) Impact Factor: 1.498 Vol. 5, Issue 6, June 2017 
83 
Asian Journal of Multidisciplinary Studies, 5(6) June, 2017 
 
  
  
 
 
 
The associations between depression and 
somatization with psychosocial symptoms 
remained significant after adjusting for the other 
psychosocial symptoms (Tables 5 and 6). 
Interestingly, anxiety at baseline was not predictive 
of pain intensity, pain interference or disability 
days at follow-up (Tables 3 and 4), but after 
adjusting for depression and somatization without 
pain, there was a significant interaction between 
anxiety and baseline CPI (p = .035) with an 
unexpected effect. Among subjects with a baseline 
CPI one standard deviation above the mean (CPI = 
65.9), subjects with moderate to severe anxiety had 
a significantly greater reduction in CPI at follow-up 
than subjects without anxiety [estimate (SE) = -
8.77 (3.77); p = .021]. 
 
Table 5. Linear regression results with all 3 psychosocial variables included in the regression model (Model 4) 
Variable Characteristic pain Pain interference Any disability days 
  intensity      
  Estimate P-value Estimate P-value RR (95% CI) P- 
  (SE)  (SE)   value 
Baseline -0.61 <.0001 -0.67 <.0001 3.33 (2.04, <.000 
  (0.04)  (0.04)  5.40)  
depression 0.21 .94 4.03 .065
3
 1.27 (0.73, .40 
  (2.63)  (2.18)  2.21)   
somatization (without 6.71 .012
1
 2.26 .31 1.79 (1.05, .031 
pain items) (2.66)  (2.20)  3.04)   
anxiety -3.71 .22
2
 -4.54 .073 0.89 (0.50, .69 
  (3.03)  (2.52)  1.58)   
*
There was significant interaction between baseline somatization and baseline CPI, p = .044. 
*
There was significant interaction between baseline anxiety and baseline CPI, p = .035 
*
There was significant interaction between baseline depression and baseline PI, p = .0006 
 
Table 6. Regression results with all 3 psychosocial variables included in the regression model (Model 4) 
Variable Characteristic pain Pain interference Any disability days 
 intensity     
 Estimate P-value Estimate P-value RR (95% P-value 
 (SE)  (SE)  CI)  
Baseline -0.63 <.0001 -0.68 <.0001 2.80 (1.72, <.0001 
 (0.04)  (0.04)  4.52)  
depression 1.53 .55 4.43 (2.11) .037 1.35 (0.78, .28 
 (2.56)    2.33)  
somatization (with 4.56 .064 1.60 (1.92) .41 1.86 (0.78, .16 
pain items) (2.46)    4.42)  
anxiety -2.01 .49 -3.40 .10 1.04 (0.58, .90 
 (2.92)  (2.43)  1.83)  
*
There was significant interaction between baseline depression and baseline PI, p = .0003 
 
Discussion 
The aim of this paper was to determine if 
psychosocial symptoms at baseline were associated 
with a change in the course of pain and its 
associated disability from baseline to follow-up. 
This prospective research reports the prediction of 
pain outcomes by using baseline psychosocial 
dysfunctions (depression, somatization, anxiety) 
and Chronic Graded Pain Scale (CGPS) in patients 
in three different demographic areas (WA, NY, 
MN) who were diagnosed with 
Temporomandibular Disorder (TMD) in terms of 
characteristics of pain intensity (CPI), pain 
interference (PI), and disability days (DD). 
The results of this research support the importance 
of psychological screening of TMD patients in 
order to evaluate the risks of depression and 
somatization that may influence treatment (58). 
Our findings indicate that a psychosocial 
assessment of TMD patients may be important as a 
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physical evaluation and may be more important 
when predicting pain outcomes. Our findings 
suggest that the clinical relevance of measuring 
psychosocial dysfunction cannot be underestimated 
(57). 
The present research performed by means of a 
prospective analysis of RDC/TMD findings, 
suggests that there might be a significant 
correlation between psychosocial impairments 
(depression, somatization with and without pain) 
and characteristic pain intensity, pain interference, 
and disability days at baseline. We found that 
psychosocial impairments (depression, 
somatization with and without pain) were 
asssociated with increased of characteristic pain 
intensity, pain interference, and disability days. 
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